Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Smits

Showing results (221-230 of 295) with videos related to

Pageof 30
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 27, 2025
The role of VISTA engagement in limiting neutrophil-mediated inflammationElizabeth C Nowak, Jiannan Li, Zachary T Peters, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 11, 2016
Impact of percutaneous coronary intervention timing on 5-year outcome in patients with non-ST-segment elevation acute coronary syndromes. The 'wait a day' approach might be saferErik F J Oosterwerff, N D Fagel, T Slagboom, et al.
Heart Rhythm|March 19, 2025
Heterogeneity in clinical judgment of septal lead position and capture type in left bundle branch area pacingJohan van Koll, Justin G L M Luermans, Jacqueline Joza, et al.
The American Journal of Cardiology|February 22, 2005
Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidancePierfrancesco Agostoni, Marco Valgimigli, Carlos A G Van Mieghem, et al.
Circulation|December 14, 2020
Effect of Prehospital Crushed Prasugrel Tablets in Patients With ST-Segment-Elevation Myocardial Infarction Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH TrialGeorgios J Vlachojannis, Jeroen M Wilschut, Rosanne F Vogel, et al.
Journal of the American College of Cardiology|October 1, 2011
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomesPatrick W Serruys, Yoshinobu Onuma, Dariusz Dudek, et al.
The Journal of Biological Chemistry|September 15, 2010
The heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and diseaseNicole C Smits, Sindhulakshmi Kurup, Angelique L Rops, et al.
JACC. Cardiovascular Interventions|June 20, 2020
Coronary Calcification and Long-Term Outcomes According to Drug-Eluting Stent GenerationPaul Guedeney, Bimmer E Claessen, Roxana Mehran, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|January 28, 2017
HS3ST1 genotype regulates antithrombin's inflammomodulatory tone and associates with atherosclerosisNicole C Smits, Takashi Kobayashi, Pratyaksh K Srivastava, et al.
Circulation. Cardiovascular Interventions|October 11, 2012
First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality studyJohn A Ormiston, Patrick W Serruys, Yoshinobu Onuma, et al.
Pageof 30

Showing results (221-230 of 295) with videos related to

Sort By:
Pageof 30
Journal of Immunology (Baltimore, Md. : 1950)|June 27, 2025
The role of VISTA engagement in limiting neutrophil-mediated inflammationElizabeth C Nowak, Jiannan Li, Zachary T Peters, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 11, 2016
Impact of percutaneous coronary intervention timing on 5-year outcome in patients with non-ST-segment elevation acute coronary syndromes. The 'wait a day' approach might be saferErik F J Oosterwerff, N D Fagel, T Slagboom, et al.
Heart Rhythm|March 19, 2025
Heterogeneity in clinical judgment of septal lead position and capture type in left bundle branch area pacingJohan van Koll, Justin G L M Luermans, Jacqueline Joza, et al.
The American Journal of Cardiology|February 22, 2005
Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidancePierfrancesco Agostoni, Marco Valgimigli, Carlos A G Van Mieghem, et al.
Circulation|December 14, 2020
Effect of Prehospital Crushed Prasugrel Tablets in Patients With ST-Segment-Elevation Myocardial Infarction Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH TrialGeorgios J Vlachojannis, Jeroen M Wilschut, Rosanne F Vogel, et al.
Journal of the American College of Cardiology|October 1, 2011
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomesPatrick W Serruys, Yoshinobu Onuma, Dariusz Dudek, et al.
The Journal of Biological Chemistry|September 15, 2010
The heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and diseaseNicole C Smits, Sindhulakshmi Kurup, Angelique L Rops, et al.
JACC. Cardiovascular Interventions|June 20, 2020
Coronary Calcification and Long-Term Outcomes According to Drug-Eluting Stent GenerationPaul Guedeney, Bimmer E Claessen, Roxana Mehran, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|January 28, 2017
HS3ST1 genotype regulates antithrombin's inflammomodulatory tone and associates with atherosclerosisNicole C Smits, Takashi Kobayashi, Pratyaksh K Srivastava, et al.
Circulation. Cardiovascular Interventions|October 11, 2012
First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality studyJohn A Ormiston, Patrick W Serruys, Yoshinobu Onuma, et al.
Pageof 30